Differential gene expression of organic anion transporters in male and female rats. 2002

Yasuna Kobayashi, and Noriko Hirokawa, and Naomi Ohshiro, and Takashi Sekine, and Tadanori Sasaki, and Shogo Tokuyama, and Hitoshi Endou, and Toshinori Yamamoto
Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan.

Sex-related differential gene expression of organic anion transporters (rOAT1, rOAT2, and rOAT3) in rat brain, liver, and kidney was investigated. There were no sex differences in the expression of rOAT1 mRNA. rOAT2 mRNA was abundant in the liver and weakly expressed in the kidney of male rats; however, the OAT2 gene was strongly expressed in both organs of females. The abundance of rOAT2 mRNA markedly increased in castrated male rat kidney; however, treatment of castrated male rats with testosterone led to a decrease of rOAT2 mRNA. Expression of rOAT3 mRNA in intact female rats was found in the kidney and brain, whereas in males rOAT3 mRNA was also found in the liver. rOAT3 mRNA markedly decreased in the liver of castrated male rats but increased in testosterone-treated castrated male rats. Moreover, rOAT3 mRNA increased in the hypophysectomized female rat liver, indicating that rOAT3 is an inducible isoform. The present findings suggest that sex steroids play an important role in the expression and maintenance of OAT2/3 isoforms in the rat liver and kidney. Our results provide information on the differential gene expression of OAT isoforms with sex hormone dependency.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012313 RNA A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) RNA, Non-Polyadenylated,Ribonucleic Acid,Gene Products, RNA,Non-Polyadenylated RNA,Acid, Ribonucleic,Non Polyadenylated RNA,RNA Gene Products,RNA, Non Polyadenylated
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor

Related Publications

Yasuna Kobayashi, and Noriko Hirokawa, and Naomi Ohshiro, and Takashi Sekine, and Tadanori Sasaki, and Shogo Tokuyama, and Hitoshi Endou, and Toshinori Yamamoto
January 2009, Hepato-gastroenterology,
Yasuna Kobayashi, and Noriko Hirokawa, and Naomi Ohshiro, and Takashi Sekine, and Tadanori Sasaki, and Shogo Tokuyama, and Hitoshi Endou, and Toshinori Yamamoto
January 2018, Poultry science,
Yasuna Kobayashi, and Noriko Hirokawa, and Naomi Ohshiro, and Takashi Sekine, and Tadanori Sasaki, and Shogo Tokuyama, and Hitoshi Endou, and Toshinori Yamamoto
August 2004, Journal of hepatology,
Yasuna Kobayashi, and Noriko Hirokawa, and Naomi Ohshiro, and Takashi Sekine, and Tadanori Sasaki, and Shogo Tokuyama, and Hitoshi Endou, and Toshinori Yamamoto
December 1999, Gastroenterology,
Yasuna Kobayashi, and Noriko Hirokawa, and Naomi Ohshiro, and Takashi Sekine, and Tadanori Sasaki, and Shogo Tokuyama, and Hitoshi Endou, and Toshinori Yamamoto
December 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Yasuna Kobayashi, and Noriko Hirokawa, and Naomi Ohshiro, and Takashi Sekine, and Tadanori Sasaki, and Shogo Tokuyama, and Hitoshi Endou, and Toshinori Yamamoto
January 1999, Pharmaceutical biotechnology,
Yasuna Kobayashi, and Noriko Hirokawa, and Naomi Ohshiro, and Takashi Sekine, and Tadanori Sasaki, and Shogo Tokuyama, and Hitoshi Endou, and Toshinori Yamamoto
October 2005, European journal of clinical investigation,
Yasuna Kobayashi, and Noriko Hirokawa, and Naomi Ohshiro, and Takashi Sekine, and Tadanori Sasaki, and Shogo Tokuyama, and Hitoshi Endou, and Toshinori Yamamoto
March 2008, Journal of pharmacological sciences,
Yasuna Kobayashi, and Noriko Hirokawa, and Naomi Ohshiro, and Takashi Sekine, and Tadanori Sasaki, and Shogo Tokuyama, and Hitoshi Endou, and Toshinori Yamamoto
October 2007, Drug metabolism and pharmacokinetics,
Yasuna Kobayashi, and Noriko Hirokawa, and Naomi Ohshiro, and Takashi Sekine, and Tadanori Sasaki, and Shogo Tokuyama, and Hitoshi Endou, and Toshinori Yamamoto
July 2002, Molecular pharmacology,
Copied contents to your clipboard!